Neuroprotection by estrogen against MPP super(+)-induced dopamine neuron death is mediated by ER alpha in primary cultures of mouse mesencephalon

Estrogen involvement in neuroprotection is now widely accepted, although the specific molecular and cellular mechanisms of estrogen action in neuroprotection remain unclear. This study examines estrogenic effects in a mixed population of cells in attempts to identify the contributing cells that result in estrogen-mediated neuroprotection. Utilizing primary mesencephalic neurons, we found expression of both estrogen receptor alpha (ER alpha ) and estrogen receptor beta (ER beta ) with a predominance of ER alpha on both dopamine neurons and astrocytes. We also found that 17 beta -estradiol protects dopamine neurons from injury induced by the complex I inhibitor, 1-methyl-4-phenyl pyridinium (MPP super(+)) in a time- and ER-dependent manner. At least 4 h of estrogen pre-treatment was required to elicit protection, an effect that was blocked by the ER antagonist, ICI 182,780. Moreover, ER alpha mediated the protection afforded by estrogen since only the ER alpha agonist, HPTE, but not the ER beta agonist, DPN, protected against dopamine cell loss. Since glial cells were shown to express significant levels of ER alpha , we investigated a possible indirect mechanism of estrogen-mediated neuroprotection through glial cell interaction. Removal of glial cells from the cultures by application of the mitotic inhibitor, 5-fluoro-2'-deoxyuridine, significantly reduced the neuroprotective effects of estrogen. These data indicate that neuroprotection provided by estrogen against MPP super(+) toxicity is mediated by ER alpha and involves an interplay among at least two cell types.